Report Detail

Chemical & Material Global Lifitegrast API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4638820
  • |
  • 24 October, 2025
  • |
  • Global
  • |
  • 87 Pages
  • |
  • GIR
  • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Lifitegrast API market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Lifitegrast is an N-acyl-L-alpha-amino acid obtained by formal condensation of the carboxy group of N-[2-(1-benzofuran-6-carbonyl)]-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxylic acid with the amino group of 3-(methanesulfonyl)-L-phenylalanine. Used for treatment of keratoconjunctivitis sicca (dry eye syndrome). It has a role as an anti-inflammatory drug and a lymphocyte function-associated antigen-1 antagonist. It is a L-phenylalanine derivative, a sulfone, a N-acyl-L-alpha-amino acid, a member of isoquinolines and a member of 1-benzofurans.
This report is a detailed and comprehensive analysis for global Lifitegrast API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lifitegrast API market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lifitegrast API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lifitegrast API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Ton), 2020-2031
Global Lifitegrast API market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Ton), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lifitegrast API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lifitegrast API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Dr. Reddy’s Laboratories Ltd., Gentec Pharmaceutical Group, Teva API, Sun Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals, Olon Spa, ScinoPharm Taiwan, Ltd, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lifitegrast API market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity≥98%
Purity<98%
Market segment by Application
Lifitegrast Ophthalmic Solutions
Others
Major players covered
Dr. Reddy’s Laboratories Ltd.
Gentec Pharmaceutical Group
Teva API
Sun Pharmaceutical Industries Ltd.
Glenmark Pharmaceuticals
Olon Spa
ScinoPharm Taiwan, Ltd
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lifitegrast API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lifitegrast API, with price, sales quantity, revenue, and global market share of Lifitegrast API from 2020 to 2025.
Chapter 3, the Lifitegrast API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lifitegrast API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Lifitegrast API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lifitegrast API.
Chapter 14 and 15, to describe Lifitegrast API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lifitegrast API Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Purity≥98%
    • 1.3.3 Purity<98%
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lifitegrast API Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Lifitegrast Ophthalmic Solutions
    • 1.4.3 Others
  • 1.5 Global Lifitegrast API Market Size & Forecast
    • 1.5.1 Global Lifitegrast API Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global Lifitegrast API Sales Quantity (2020-2031)
    • 1.5.3 Global Lifitegrast API Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Dr. Reddy’s Laboratories Ltd.
    • 2.1.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.1.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.1.3 Dr. Reddy’s Laboratories Ltd. Lifitegrast API Product and Services
    • 2.1.4 Dr. Reddy’s Laboratories Ltd. Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates
  • 2.2 Gentec Pharmaceutical Group
    • 2.2.1 Gentec Pharmaceutical Group Details
    • 2.2.2 Gentec Pharmaceutical Group Major Business
    • 2.2.3 Gentec Pharmaceutical Group Lifitegrast API Product and Services
    • 2.2.4 Gentec Pharmaceutical Group Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Gentec Pharmaceutical Group Recent Developments/Updates
  • 2.3 Teva API
    • 2.3.1 Teva API Details
    • 2.3.2 Teva API Major Business
    • 2.3.3 Teva API Lifitegrast API Product and Services
    • 2.3.4 Teva API Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Teva API Recent Developments/Updates
  • 2.4 Sun Pharmaceutical Industries Ltd.
    • 2.4.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.4.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.4.3 Sun Pharmaceutical Industries Ltd. Lifitegrast API Product and Services
    • 2.4.4 Sun Pharmaceutical Industries Ltd. Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.5 Glenmark Pharmaceuticals
    • 2.5.1 Glenmark Pharmaceuticals Details
    • 2.5.2 Glenmark Pharmaceuticals Major Business
    • 2.5.3 Glenmark Pharmaceuticals Lifitegrast API Product and Services
    • 2.5.4 Glenmark Pharmaceuticals Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
  • 2.6 Olon Spa
    • 2.6.1 Olon Spa Details
    • 2.6.2 Olon Spa Major Business
    • 2.6.3 Olon Spa Lifitegrast API Product and Services
    • 2.6.4 Olon Spa Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Olon Spa Recent Developments/Updates
  • 2.7 ScinoPharm Taiwan, Ltd
    • 2.7.1 ScinoPharm Taiwan, Ltd Details
    • 2.7.2 ScinoPharm Taiwan, Ltd Major Business
    • 2.7.3 ScinoPharm Taiwan, Ltd Lifitegrast API Product and Services
    • 2.7.4 ScinoPharm Taiwan, Ltd Lifitegrast API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 ScinoPharm Taiwan, Ltd Recent Developments/Updates

3 Competitive Environment: Lifitegrast API by Manufacturer

  • 3.1 Global Lifitegrast API Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global Lifitegrast API Revenue by Manufacturer (2020-2025)
  • 3.3 Global Lifitegrast API Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of Lifitegrast API by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 Lifitegrast API Manufacturer Market Share in 2024
    • 3.4.3 Top 6 Lifitegrast API Manufacturer Market Share in 2024
  • 3.5 Lifitegrast API Market: Overall Company Footprint Analysis
    • 3.5.1 Lifitegrast API Market: Region Footprint
    • 3.5.2 Lifitegrast API Market: Company Product Type Footprint
    • 3.5.3 Lifitegrast API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lifitegrast API Market Size by Region
    • 4.1.1 Global Lifitegrast API Sales Quantity by Region (2020-2031)
    • 4.1.2 Global Lifitegrast API Consumption Value by Region (2020-2031)
    • 4.1.3 Global Lifitegrast API Average Price by Region (2020-2031)
  • 4.2 North America Lifitegrast API Consumption Value (2020-2031)
  • 4.3 Europe Lifitegrast API Consumption Value (2020-2031)
  • 4.4 Asia-Pacific Lifitegrast API Consumption Value (2020-2031)
  • 4.5 South America Lifitegrast API Consumption Value (2020-2031)
  • 4.6 Middle East & Africa Lifitegrast API Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global Lifitegrast API Sales Quantity by Type (2020-2031)
  • 5.2 Global Lifitegrast API Consumption Value by Type (2020-2031)
  • 5.3 Global Lifitegrast API Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global Lifitegrast API Sales Quantity by Application (2020-2031)
  • 6.2 Global Lifitegrast API Consumption Value by Application (2020-2031)
  • 6.3 Global Lifitegrast API Average Price by Application (2020-2031)

7 North America

  • 7.1 North America Lifitegrast API Sales Quantity by Type (2020-2031)
  • 7.2 North America Lifitegrast API Sales Quantity by Application (2020-2031)
  • 7.3 North America Lifitegrast API Market Size by Country
    • 7.3.1 North America Lifitegrast API Sales Quantity by Country (2020-2031)
    • 7.3.2 North America Lifitegrast API Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe Lifitegrast API Sales Quantity by Type (2020-2031)
  • 8.2 Europe Lifitegrast API Sales Quantity by Application (2020-2031)
  • 8.3 Europe Lifitegrast API Market Size by Country
    • 8.3.1 Europe Lifitegrast API Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe Lifitegrast API Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lifitegrast API Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific Lifitegrast API Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific Lifitegrast API Market Size by Region
    • 9.3.1 Asia-Pacific Lifitegrast API Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific Lifitegrast API Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America Lifitegrast API Sales Quantity by Type (2020-2031)
  • 10.2 South America Lifitegrast API Sales Quantity by Application (2020-2031)
  • 10.3 South America Lifitegrast API Market Size by Country
    • 10.3.1 South America Lifitegrast API Sales Quantity by Country (2020-2031)
    • 10.3.2 South America Lifitegrast API Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lifitegrast API Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa Lifitegrast API Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa Lifitegrast API Market Size by Country
    • 11.3.1 Middle East & Africa Lifitegrast API Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa Lifitegrast API Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 Lifitegrast API Market Drivers
  • 12.2 Lifitegrast API Market Restraints
  • 12.3 Lifitegrast API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lifitegrast API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lifitegrast API
  • 13.3 Lifitegrast API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lifitegrast API Typical Distributors
  • 14.3 Lifitegrast API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lifitegrast API. Industry analysis & Market Report on Lifitegrast API is a syndicated market report, published as Global Lifitegrast API Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Lifitegrast API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report